Home > Drug Search >
  • company_query: BriaCell Therapeutics Corp
  •   > 
Drug Filter
Category:
chemistry (17) biology (21)
Status:
Approved (1) NDA Filing (1) Phase Ⅲ (4) Phase Ⅱ (19) Phase Ⅰ (13)
Clinical Stage:
Pending (8) Active (20) Discontinued (9)
Bio-Type:
Vaccine (15) Recombinant hormone (1) Whole antibody (3) Fusion protein (1)
Indication:
Atherosclerosis (1) Atopic dermatitis (1) Benign prostatic hypertrophy (1) Breast cancer (1) Common warts (1) Urogenital cancer (1) Follicular lymphoma (1) Gastric cancer (2) Growth hormone deficit (1) Hyperlipidemia (1) Melanoma (1) Migraine (1) Multiple myeloma (MM) (3) Obesity (1) Ovarian cancer (2) Postherpetic neuralgia (PHN) (1) Pertussis (1) Rheumatoid arthritis (RA) (1) Solid tumours (4) Type 2 diabetes (1) Visceral leishmaniasis (1) Head and neck cancer (1) Leg ulcer (1) Colorectal cancer (1) Diabetic foot ulcers (1) Reversal of Neuromuscular Blockade (1) Malaria (1) Sickle cell disease (1) Renal carcinoma (1) Contraception (1) Terminate pregnancy (1) Glioblastoma (1) Mesothelioma (1) Cocaine abuse (1) Thelassemia (1) Seborrheic keratosis (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top